November 3, 2026

Effective December 7, 2026, we will be implementing a new drug policy: DR.027.A Waskyra (etuvetidigene autotemcel).

You can access this policy by visiting our policy bulletin library.

As a reminder, our medical policy bulletins define medical necessity criteria and coverage positions on topics such as medical services, procedures, DME, therapies, etc., while our claim payment policy bulletins provide reimbursement rules and billing guidelines necessary to ensure timely and appropriate payment.